Acrisure Capital Management’s Dillards DDS Stock Holding History

Acrisure Capital Management’s Portfolio DDS Stock Details DDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-746	Closed	-$230K	–	66
2023 Q1	$230K	Buy	+746	New	+$265K	0.23%	206

Other funds holding DDS

Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CWM

ClientFirst Wealth Management Little Rock, Arkansas $118M AUM 40.43% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acrisure Capital Management's DDS Position: Q2 2023 in Review

Acrisure Capital Management sold out of Dillards (DDS) in Q2 2023, closing a stake of 746 shares — an estimated $230K sold.

Acrisure Capital Management first reported a position in DDS in Q1 2023 and held it in 1 quarter. The position peaked at $230K in Q1 2023. 202 funds tracked by Wall St. Rank hold DDS as of Q2 2023.

Acrisure Capital Management reported no remaining Dillards position as of Q2 2023 after selling out during the quarter.
Acrisure Capital Management sold 746 Dillards shares in Q2 2023, an estimated $230K.
Acrisure Capital Management first reported a position in Dillards in Q1 2023 and held it in 1 quarter.
Acrisure Capital Management's Dillards position peaked at $230K in Q1 2023.
202 funds tracked by Wall St. Rank held Dillards as of Q2 2023.

Based on Acrisure Capital Management's 13F filing for Q2 2023.